DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Shanafelt TD, Wang V, Kay NE. et al.
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy Vs. Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL): A Trial of the ECOG-ACRIN Cancer Research Group (E1912).
Blood 2018;
132: LBA-4
We do not assume any responsibility for the contents of the web pages of other providers.